BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 322655)

  • 1. Inhibition of the reconstitution of the haemolytic activity of the first component of human complement by a pepsin-derived fragment of subcomponent C1q.
    Reid KB; Sim RB; Faiers AP
    Biochem J; 1977 Feb; 161(2):239-45. PubMed ID: 322655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin.
    Brodsky-Doyle B; Leonard KR; Reid KB
    Biochem J; 1976 Nov; 159(2):279-86. PubMed ID: 187173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unactivated form of the first component of human complement, C1.
    Gigli I; Porter RR; Sim RB
    Biochem J; 1976 Sep; 157(3):541-8. PubMed ID: 985398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of the first component of complement by human fibroblasts.
    Reid KB; Solomon E
    Biochem J; 1977 Dec; 167(3):647-60. PubMed ID: 603627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation, by partial pepsin digestion, of the three collagen-like regions present in subcomponent Clq of the first component of human complement.
    Reid KB
    Biochem J; 1976 Apr; 155(1):5-17. PubMed ID: 7240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG.
    Wautier JL; Souchon H; Solal LC; Peltier AP; Caen JP
    Immunology; 1976 Oct; 31(4):595-9. PubMed ID: 185144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of subcomponent C1q of the first component of bovine complement.
    Campbell RD; Booth NA; Fothergill JE
    Biochem J; 1979 Feb; 177(2):531-40. PubMed ID: 219845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the first component of human complement (C1) by antibody-antigen aggregates.
    Dodds AW; Sim RB; Porter RR; Kerr MA
    Biochem J; 1978 Nov; 175(2):383-90. PubMed ID: 743203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody to C1q which appears to interact with C1r2C1s2-binding site.
    Hsiung L; Dodds AW; Mason DW; Reid KB
    FEBS Lett; 1988 Feb; 229(1):21-4. PubMed ID: 2831088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.
    Sim RB; Arlaud GJ; Colomb MG
    Biochem J; 1979 Jun; 179(3):449-57. PubMed ID: 475762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4.
    Aubert B; Chesne S; Arlaud GJ; Colomb MG
    Biochem J; 1985 Dec; 232(2):513-9. PubMed ID: 3911948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of EDTA and citrate on the functional activity of the first component of complement, C1, and the C1q subcomponent.
    Zapf S; Loos M
    Immunobiology; 1985 Sep; 170(3):123-32. PubMed ID: 3932188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis of the subcomponents C1q, C1r and C1s of the first component of complement (C1) by guinea pig hepatocyte primary cultures.
    Ramadori G; Heinz HP; Martin H; Meyer zum Büschenfelde KH; Loos M
    Eur J Immunol; 1986 Sep; 16(9):1137-41. PubMed ID: 3019707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and some properties of rabbit C1r.
    Mori Y; Koketsu M; Abe N; Koyama J
    J Biochem; 1979 Apr; 85(4):1023-8. PubMed ID: 457626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
    Bernard A; Walter W; Teshima H; Boumsell L; Good RA; Day NK
    J Immunol; 1976 Oct; 117(4):1117-26. PubMed ID: 977945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stepwise dissociation of subcomponents of C1, the first component of human complement, upon activation on an affinity sorbent].
    Kozlov LV; Shoĭbonov BB; Ivanov AE; Zubov VP; Antonov VK
    Biokhimiia; 1989 Oct; 54(10):1745-51. PubMed ID: 2605275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.